Syntax Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$208K Buy
12,005
+389
+3% +$8.11K 0.18% 175
2023
Q2
$242K Buy
11,616
+1,053
+10% +$22.9K 0.19% 138
2023
Q1
$248K Buy
10,563
+1,607
+18% +$43.1K 0.19% 156
2022
Q4
$250K Buy
8,956
+341
+4% +$8.72K 0.21% 124
2022
Q3
$202K Buy
8,615
+1,830
+27% +$55.3K 0.17% 188
2022
Q2
$229K Buy
6,785
+377
+6% +$13.2K 0.19% 158
2022
Q1
$224K Sell
6,408
-2,654
-29% -$90.8K 0.19% 180
2021
Q4
$276K Buy
+9,062
New +$295K 0.2% 140

Other funds holding OGN

Syntax Advisors's OGN Position: Q3 2023 in Review

Syntax Advisors increased its Organon & Co (OGN) stake by 3.3% in Q3 2023, buying an estimated $8.11K and bringing the position to 12,005 shares worth $208K. The position accounts for 0.18% of the portfolio, ranked #175.

Syntax Advisors first reported a position in OGN in Q4 2021 and has held it in 8 quarters since. The position peaked at $276K in Q4 2021. 730 funds tracked by Wall St. Rank hold OGN as of Q3 2023.

  • Syntax Advisors held 12,005 shares of Organon & Co worth $208K as of Q3 2023.
  • Syntax Advisors bought 389 Organon & Co shares in Q3 2023, an estimated $8.11K.
  • Organon & Co made up 0.18% of Syntax Advisors's portfolio in Q3 2023, its #175 holding.
  • Syntax Advisors first reported a position in Organon & Co in Q4 2021 and has held it in 8 quarters since.
  • Syntax Advisors's Organon & Co position peaked at $276K in Q4 2021.
  • 730 funds tracked by Wall St. Rank held Organon & Co as of Q3 2023.

Based on Syntax Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.